Patent · US Active

Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate

US8153668B2 · kind B2 · utility

0Cited by

3References

4Claims

0Family size

Assignee

Vertex Pharmaceuticals Incorporated · US

Inventors

Todd Blythe · Georgetown, US
Alex Eberlin · Cambridge, GB
Michael Laird Hurrey · San Ramon, US
David Jonaitis · Lafayette, US
Philip Nyce · Millbury, US
Stephan D. Parent · West Lafayette, US
John R. Snoonian · Bolton, US

Key dates

Filing date	Sep 8, 2009
Grant date	Apr 10, 2012
Priority date	—
Expiry date	Sep 8, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P41/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to polymorphic forms of (S)-tetrahydrofuran-3-yl 3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate, processes therein, pharmaceutical compositions thereof, and uses therewith.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.